Tirzepatide is the active ingredient in the well-known medication brands, Mounjaro and Zepbound.
  • Non-stimulating
  • Safe and effective for long-term use
  • Clients are monitored monthly for safety and efficacy
  • Reduced appetite
  • Noticeable weight loss can occur within the first 1-2 months

How It Works

Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist is a dual-action treatment for controlling blood sugar and weight loss.

Important Safety Information

Mechanism of Action: Tirzepatide is both a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. It selectively binds to and activates the GIP and GLP-1 receptors, the targets for native GIP and GLP-1 hormones. GIP and GIP-1 are hormones that are primarily released from the body’s small intestine that enhances the release of insulin following the consumption of food. Both of these hormones are known as incretins, with Tirzepatide belonging to a class of drugs known as incretin mimetics. Tirzepatide works by directly activating GIP and GLP-1 pathways to help regulate blood sugar.

Adverse Reactions: The most common side effects of Tirzepatide include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach (abdominal) pain. These are not all the possible side effects of Tirzepatide. Please discuss with your physician the contraindications and other warnings and precautions before starting Tirzepatide.

What Benefits Have Been Reported?

  • Weight loss
  • Lower A1c
  • Lower blood sugar
  • Increased insulin secretion
  • Reduced appetite
  • Lower blood pressure